+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Controlling drug delivery from coronary stents: are we aiming for the right targets?



Controlling drug delivery from coronary stents: are we aiming for the right targets?



Therapeutic Delivery 6(6): 705-720



In this review article, the currently employed or explored delivery concepts for local intravascular drug delivery with drug-eluting stents (DES) are discussed with a special emphasis on clinical evidence regarding the desired release profiles. Traditional concepts to control drug release from DES include diffusion through polymers, polymer degradation and erosion as well as dissolution of particulate drug. Published clinical studies do not always reveal fine mechanistic details. The long duration of release favored for DES and the short duration of release favored for drug-eluting balloons require further investigation in experimental studies and clinical trials.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057505497

Download citation: RISBibTeXText

PMID: 26149786

DOI: 10.4155/tde.15.25


Related references

Comparison of Drug-eluting Coronary Stents, Bare Coronary Stents and Self-expanding Stents in Angioplasty of Middle Cerebral Artery Stenoses. Journal of Cerebrovascular and Endovascular Neurosurgery 15(2): 85-95, 2013

Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries. Jacc. Cardiovascular Interventions 2(4): 277-283, 2009

Comparison of Chronic Angioscopic Findings of Bare Metal Stents, 1st-Generation Drug-Eluting Stents and 2nd-Generation Drug-Eluting Stents - Multicenter Study of Intra-Coronary Angioscopy After Stent (MICASA). Circulation Journal 80(9): 1916-1921, 2016

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis. Bmj 347(): F6625-F6625, 2014

Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes. American Journal of Cardiology 103(2): 187-193, 2009

Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. Jacc. Cardiovascular Interventions 9(18): 1890-1901, 2016

Outcomes of intravascular ultrasound-guided percutaneous coronary intervention with drug-eluting stents versus bare metal stents for acute coronary syndrome in octogenarians. Angiology 62(8): 620-624, 2012

Impairment factors for evaluating the patency of drug-eluting stents and bare metal stents in coronary arteries by 64-slice computed tomography versus conventional coronary angiography. International Journal of Cardiology 130(3): 349-356, 2008

Comparison of bare metal stents versus drug-eluting stents on clinical decision making in patients with previous percutaneous coronary intervention admitted for suspected acute coronary syndrome. American Journal of Cardiology 98(3): 338-340, 2006

Aiming drug discovery at lysophosphatidic acid targets. British Journal of Pharmacology 161(2): 241-270, 2011

Time course of endothelium-dependent and -independent coronary vasomotor response to coronary balloons and stents. Comparison of plain and drug-eluting balloons and stents. Jacc. Cardiovascular Interventions 5(7): 741-751, 2012

Meta-analysis of everolimus-eluting stents versus first-generation drug-eluting stents in patients with left main coronary artery undergoing percutaneous coronary intervention. International Journal of Cardiology 168(2): 1718-1719, 2014

Drug development in schizophrenia: are glutamatergic targets still worth aiming at?. Current Opinion in Psychiatry 28(3): 207-215, 2016

Outcomes of overlapping heterogeneous drug-eluting stents versus homogeneous drug-eluting stents for diffuse lesions in small coronary arteries. Journal of Interventional Cardiology 26(3): 264-270, 2014

Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents for patients with coronary artery disease: an update meta-analysis. Cardiovascular Drugs and Therapy 28(4): 379-385, 2015